Lymphoblastic (diffuse) lymphoma affecting the intrapelvic lymph nodes is a type of aggressive non-Hodgkin lymphoma characterized by the proliferation of immature lymphoid cells. This condition is clinically significant due to its rapid progression and potential for systemic involvement. Accurate coding with ICD-10 Code C83.56 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this serious condition.
ICD-10 Code C83.56 specifically denotes lymphoblastic (diffuse) lymphoma localized in the intrapelvic lymph nodes. This aggressive lymphoma is characterized by the presence of immature lymphocytes and can lead to significant morbidity if not promptly diagnosed and treated. This code should be used in clinical documentation and billing when a patient presents with this specific type of lymphoma, ensuring accurate representation of the patient's condition.
Lymphoblastic (diffuse) lymphoma, particularly when involving intrapelvic lymph nodes, is a hematological malignancy that arises from immature lymphoid cells. This condition requires immediate medical attention due to its aggressive nature and potential for rapid progression. Early diagnosis and treatment are crucial for improving patient outcomes.
In SOAP notes, ICD-10 Code C83.56 plays a critical role in documenting the patient's symptoms, assessment findings, and treatment plans. This code aids in ensuring accurate billing and compliance with healthcare regulations, applicable in both acute and chronic care settings.
ICD-10 Code C83.56 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of lymphoblastic lymphoma. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
The management of lymphoblastic (diffuse) lymphoma requires prompt and aggressive treatment strategies, often necessitating hospitalization.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C83.56 is crucial for accurate billing in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 99223 | Initial hospital care, typically 70 minutes or more. |
| 36415 | Collection of venous blood by venipuncture. |
Common Questions About Using ICD-10 Code C83.56 for Lymphoblastic (diffuse) lymphoma, intrapelvic lymph nodes
What are the common symptoms of lymphoblastic lymphoma?
Common symptoms include swollen lymph nodes, fever, night sweats, and unexplained weight loss. Patients may also experience abdominal pain if the lymphoma affects the intrapelvic area.
How is lymphoblastic lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy of affected lymph nodes to confirm the presence of immature lymphoid cells.
What is the treatment for lymphoblastic lymphoma?
Treatment usually consists of aggressive chemotherapy regimens, and in some cases, stem cell transplantation may be considered depending on the patient's response and overall health.
Is lymphoblastic lymphoma common in certain age groups?
Yes, lymphoblastic lymphoma is more prevalent in adolescents and young adults, particularly males, making early detection and treatment critical in these populations.
Clinical Notes
SOAP notes
DAP notes
AI medical notes